Inova Diagnostics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Inova Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010993
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Inova Diagnostics Inc (Inova), a subsidiary of Werfen Life Group SAU is a medical device company that develops and commercializes new autoimmune technologies and diagnostic markers. The company’s diagnostic reagent products include QUANTA Flash used for semi-quantitative determination of auto-antibodies; QUANTA Lite used to enable semi-quantitative detection of auto-antibodies in human serum; Nova Lite; Nova Dot; Nova Gel; and Quanta Chek. Inova provides automation instruments such as BIO-FLASH, QUANTA Link, NOVA View, QUANTA-Lyser family of products, DSX/best 2000 and DS2. The company offers tests and technologies for the treatment of diseases such as celiac, anti-phospholipid syndrome, connective tissue, gastrointestinal, rheumatoid arthritis, vasculitis and other diseases. Inova is headquartered in San Diego, California, the US.

Inova Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Inova Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Inova Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Inova Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Inova Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Inova Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Inova Diagnostics Inc, Medical Equipment, Deal Details 10
Partnerships 10
Inova Diagnostics Enters into Licensing Agreement with Hasselt University 10
Leiden University Enters Into Licensing Agreement With Inova Diagnostics For Rheumatoid Arthritis 11
INOVA Diagnostics Enters Into Licensing Agreement With AmberGen And Massachusetts General Hospital For Two Autoantigen Biomarkers 12
ImmusanT Enters Into Co-Development Agreement With Inova Diagnostics 13
Inova Diagnostics Enters into Licensing Agreement with Protagen 14
Inova Diagnostics Inc – Key Competitors 15
Inova Diagnostics Inc – Key Employees 16
Inova Diagnostics Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Inova Diagnostics Inc, Medical Equipment, Key Facts 2
Inova Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Inova Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Inova Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Inova Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Inova Diagnostics Inc, Deals By Market, 2011 to YTD 2017 8
Inova Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Inova Diagnostics Enters into Licensing Agreement with Hasselt University 10
Leiden University Enters Into Licensing Agreement With Inova Diagnostics For Rheumatoid Arthritis 11
INOVA Diagnostics Enters Into Licensing Agreement With AmberGen And Massachusetts General Hospital For Two Autoantigen Biomarkers 12
ImmusanT Enters Into Co-Development Agreement With Inova Diagnostics 13
Inova Diagnostics Enters into Licensing Agreement with Protagen 14
Inova Diagnostics Inc, Key Competitors 15
Inova Diagnostics Inc, Key Employees 16

★海外企業調査レポート[Inova Diagnostics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SunVic Chemical Holdings Ltd (A7S):企業の財務・戦略的SWOT分析
    SunVic Chemical Holdings Ltd (A7S) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Cosmo Bio Co Ltd (3386):企業の財務・戦略的SWOT分析
    Summary Cosmo Bio Co Ltd (Cosmo Bio) operates as a medical device company that offers markets research reagents and research instruments. The company’s product categories include antibodies, assay and detection, cells and cell culture, bioactive substances, protein engineering, separation and purifi …
  • Hitachi Ltd (6501):企業の財務・戦略的SWOT分析
    Hitachi Ltd (6501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • RhythmOne plc:企業のM&A・事業提携・投資動向
    RhythmOne plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RhythmOne plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Abcodia Ltd:企業の製品パイプライン分析2018
    Summary Abcodia Ltd (Abcodia) is a clinical stage company that offers commercial development of novel, scientifically validated tests for the early detection of cancer. The company offers Roca Test, a blood test for early ovarian cancer detection. It validates and discovers biomarkers for early diag …
  • Alnylam Pharmaceuticals Inc (ALNY):企業の財務・戦略的SWOT分析
    Alnylam Pharmaceuticals Inc (ALNY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Serodus ASA (SER)-製薬・医療分野:企業M&A・提携分析
    Summary Serodus ASA (Serodus) is a drug development company that focuses on the development of products for unmet medical needs in areas such as diabetes and diabetic comorbidities. The company’s pipeline products include SER150DN, an anti-inflammatory compound under development for diabetic nephrop …
  • Cryosite Ltd (CTE):企業の財務・戦略的SWOT分析
    Summary Cryosite Ltd (Cryosite) is a healthcare solution provider that offers clinical trials outsourced logistics services to research, medical, pharmaceutical, veterinary and biotechnology industries. The company manufactures stem cell products for both therapeutic use and clinical trials. It prov …
  • Aecon Group Inc (ARE):企業の財務・戦略的SWOT分析
    Aecon Group Inc (ARE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • PDS Biotechnology Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops vaccines and immunotherapies for cancer and infectious disease. The company uses versamune technology that is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunothera …
  • Welspun India Ltd (WELSPUNIND):企業の財務・戦略的SWOT分析
    Welspun India Ltd (WELSPUNIND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Edge Therapeutics Inc (EDGE)-製薬・医療分野:企業M&A・提携分析
    Summary Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes a range of hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, …
  • Renova Energia SA (RNEW11)-エネルギー分野:企業M&A・提携分析
    Summary Renova Energia S.A. (Renova Energia) is a renewable power generation company. It develops, implements and operates power generation projects based on renewable energy sources such as wind, small hydropower and solar; and sells electricity. It also undertakes activities related to manufacturi …
  • Regions Financial Corporation:戦略・SWOT・企業財務分析
    Regions Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Regions Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Infinity Pharmaceuticals Inc (INFI):製薬・医療:M&Aディール及び事業提携情報
    Summary Infinity Pharmaceuticals Inc (Infinity Pharmaceuticals) is a biopharmaceutical company that discovers and develops small molecule therapeutics for the treatment of cancer. The company’s pipeline candidate: IPI-549 selectively inhibits PI3K-gamma to reprogram tumor-associated macrophages and …
  • Sangamo Therapeutics Inc (SGMO):製薬・医療:M&Aディール及び事業提携情報
    Summary Sangamo Therapeutics Inc (Sangamo), formerly Sangamo BioSciences Inc, is a clinical stage biotechnology company that focuses on the research, development and commercialization of engineered DNA-binding proteins (ZFPs) for gene regulation, cell therapy and therapeutic genome editing. Its prod …
  • Karambunai Corporation Berhad:戦略・SWOT・企業財務分析
    Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Allegion Plc:企業の戦略・SWOT・財務情報
    Allegion Plc - Strategy, SWOT and Corporate Finance Report Summary Allegion Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Deciphera Pharmaceuticals LLC (DCPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Deciphera Pharmaceuticals LLC (Deciphera Pharmaceuticals) is a research and development company that develops, designs, and commercializes kinase inhibiting drugs. The company provides clinical pipeline of kinase inhibitors such as tumor-targeted therapies and immuno-targeted therapies. It u …
  • BioMedomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioMedomics Inc (BioMedomics) is a point-of-care diagnostics company that develops and markets immunologically-based disease-specific tests and advanced highly sensitive quantitative platforms. The company provides technologies such as time-resolved lateral flow immunoassay and nanotube base …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆